Osteoarthritis News and Research

Latest Osteoarthritis News and Research

Clinical practice guidelines for osteoarthritis of the knee

Clinical practice guidelines for osteoarthritis of the knee

Obesity: A musculoskeletal nightmare

Obesity: A musculoskeletal nightmare

A stem cell bandage for your knee

A stem cell bandage for your knee

New weapon in the battle against obesity

New weapon in the battle against obesity

After knee replacement exercise is crucial

After knee replacement exercise is crucial

New imaging technique catches arthritis early

New imaging technique catches arthritis early

Study looks at acupuncture for pain

Study looks at acupuncture for pain

Exercise no danger for joints

Exercise no danger for joints

Gene therapy for rheumatoid arthritis: promising results

Gene therapy for rheumatoid arthritis: promising results

Loss of sex drive after menopause affects health, quality of life

Loss of sex drive after menopause affects health, quality of life

Savella - Fibromyalgia treatment approved by FDA

Savella - Fibromyalgia treatment approved by FDA

Strong quadriceps may benefit those with knee osteoarthritis

Strong quadriceps may benefit those with knee osteoarthritis

Discovery of cause of cartilage degeneration in osteoarthritis

Discovery of cause of cartilage degeneration in osteoarthritis

Health-care providers and patients differ on views of knee replacement

Health-care providers and patients differ on views of knee replacement

Pycnogenol reduces inflammatory marker C-reactive protein in osteoarthritis

Pycnogenol reduces inflammatory marker C-reactive protein in osteoarthritis

FDA advisory committee to dscuss PMA for Genzyme's Synvisc-One

FDA advisory committee to dscuss PMA for Genzyme's Synvisc-One

NicOx signs agreement with DSM for the commercial manufacture of naproxcinod drug substance

NicOx signs agreement with DSM for the commercial manufacture of naproxcinod drug substance

Horizon Therapeutics announces HZT-501 trials meet primary endpoints

Horizon Therapeutics announces HZT-501 trials meet primary endpoints

Smart materials to revolutionise surgical implants

Smart materials to revolutionise surgical implants

Eli Lilly withdraws application for additional U.S. indication for Cymbalta for chronic pain

Eli Lilly withdraws application for additional U.S. indication for Cymbalta for chronic pain

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.